Atlas Trials

Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod

Clinical trial NCT01790269 · TERMINATED

Trial details

NCT number
NCT01790269
Sponsor
Charite University, Berlin, Germany
Status
TERMINATED
Study type
OBSERVATIONAL
Relapsing-Remitting Multiple Sclerosis
Start date
2013-09-01
Primary completion
2018-08-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.